Pharmaceutical

Patient comfort in AI-driven healthcare linked to familiarity with technology

Patient comfort in AI-driven healthcare linked to famil...

Oct 13, 2023

As the healthcare landscape undergoes transformation due to factors like aging ...

Listen: Merger Mondays, Ozempic panic, & CRISPR’d pigs

Oct 12, 2023

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozem...

STAT+: Scientists have mapped the human brain in unprecedented detail. They’re just getting started

STAT+: Scientists have mapped the human brain in unprec...

Oct 12, 2023

This brain map is essentially a cellular “parts list” of the human brain and a g...

STAT+: Better Therapeutics data on apps’ benefit with GLP-1s, Orexo hits a snag

STAT+: Better Therapeutics data on apps’ benefit with G...

Oct 12, 2023

In the latest edition of STAT's Health Tech newsletter: Better Therapeutics data...

Cell and gene therapies could be a safer bet than other drugs

Cell and gene therapies could be a safer bet than other...

Oct 12, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail

STAT+: Pharmalittle: Life sciences deals on track to hi...

Oct 12, 2023

Both the number of deals and the amount of money being invested in life science ...

STAT+: EU orders Illumina to divest cancer diagnostics firm Grail

STAT+: EU orders Illumina to divest cancer diagnostics ...

Oct 12, 2023

The EU in 2022 ruled that the purchase violated antitrust rules, and Thursday’s ...

Opinion: How kangaroo mother care can help millions of babies each year

Opinion: How kangaroo mother care can help millions of ...

Oct 12, 2023

Centering mothers and families in the care of preterm infants and keeping mother...

Treating Rural America: The new country doctors

Treating Rural America: The new country doctors

Oct 12, 2023

The second installment of STAT's rural health series explores why rural residenc...

STAT+: Peter Marks on creating Operation Warp Speed, but for rare diseases

STAT+: Peter Marks on creating Operation Warp Speed, bu...

Oct 12, 2023

Peter Marks wants drug developers to ask more stupid questions. It’s part of the...

STAT+: Life sciences deals on track to hit lowest point since 2017

STAT+: Life sciences deals on track to hit lowest point...

Oct 12, 2023

It’s no secret that biotech industry funding has fallen from its Covid highs. Bu...

STAT+: Key takeaways from AdvaMed, the world’s largest medical device conference

STAT+: Key takeaways from AdvaMed, the world’s largest ...

Oct 12, 2023

As AdvaMed concludes, here are the key takeaways from the world’s largest medica...

STAT+: CRO claims there was no misconduct in Lyme vaccine trial it ran for Pfizer

STAT+: CRO claims there was no misconduct in Lyme vacci...

Oct 12, 2023

A company that Pfizer blamed for problems with a clinical trial testing a Lyme v...

STAT+: Humana CEO Bruce Broussard to step down next year

STAT+: Humana CEO Bruce Broussard to step down next year

Oct 12, 2023

Bruce Broussard will leave Humana next year. Jim Rechtin, CEO of the bankrupt En...

STAT+: Medicare may plan to negotiate drug prices, but some states are taking their own steps to lower costs

STAT+: Medicare may plan to negotiate drug prices, but ...

Oct 12, 2023

A handful of states are moving aggressively to slash drug costs for their reside...

STAT+: European regulators consider appeal over Amylyx ALS drug

STAT+: European regulators consider appeal over Amylyx ...

Oct 12, 2023

This week, European regulators are considering an appeal from Amylyx Pharmaceuti...